{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:41:30Z","timestamp":1761986490534,"version":"3.44.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jaci.2015.10.051","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T21:54:50Z","timestamp":1455314090000},"page":"229-240.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Reduction of CRKL expression in patients with partial DiGeorge syndrome is associated with impairment of T-cell functions"],"prefix":"10.1016","volume":"138","author":[{"given":"Mauro","family":"Giacomelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annarosa","family":"Soresina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Tamassia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Lorenzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Moratto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Gasperini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Cassatella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilios","family":"Lougaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7375-5410","authenticated-orcid":false,"given":"Raffaele","family":"Badolato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2015.10.051_bib1","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1038\/sj.onc.1204779","article-title":"Crk family adaptors-signalling complex formation and biological roles","volume":"20","author":"Feller","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.jaci.2015.10.051_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-811X-7-13","article-title":"Crk and CrkL adaptor proteins: networks for physiological and pathological signaling","volume":"7","author":"Birge","year":"2009","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jaci.2015.10.051_bib3","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.cellsig.2006.05.001","article-title":"CrkL plays a role in SDF-1\u0391 -induced activation of the Raf-1\/MEK\/Erk pathway through Ras and Rac to mediate chemotactic signaling in hematopoietic cells","volume":"18","author":"Arai","year":"2006","journal-title":"Cell Signal"},{"key":"10.1016\/j.jaci.2015.10.051_bib4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0301-472X(99)00154-X","article-title":"Thrombopoietin induces the generation of distinct Stat1, Stat3, Stat5a and Stat5b homo- and heterodimeric complexes with different kinetics in human platelets","volume":"28","author":"Schulze","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jaci.2015.10.051_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/bbrc.2000.3803","article-title":"Thrombopoietin and interleukin-2 induce association of CRK with STAT5","volume":"278","author":"Oda","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaci.2015.10.051_bib6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1074\/jbc.274.2.571","article-title":"Activation of a CrkL-stat5 signaling complex by type I interferons","volume":"274","author":"Fish","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2015.10.051_bib7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2337\/diabetes.55.03.06.db05-1059","article-title":"Impaired Crkl expression contributes to the defective DNA binding of Stat5b in nonobese diabetic mice","volume":"55","author":"Laloraya","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jaci.2015.10.051_bib8","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1128\/MCB.22.5.1412-1423.2002","article-title":"Apoptotic regulation by the Crk adapter protein mediated by interactions with Wee1 and Crm1\/exportin","volume":"22","author":"Smith","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jaci.2015.10.051_bib9","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1083\/jcb.151.7.1391","article-title":"Wee1-regulated apoptosis mediated by the crk adaptor protein in Xenopus egg extracts","volume":"151","author":"Smith","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jaci.2015.10.051_bib10","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.4049\/jimmunol.147.8.2734","article-title":"Nuclear transcription factors that bind to elements of the IL-2 promoter. Induction requirements in primary human T cells","volume":"147","author":"Granelli-Piperno","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2015.10.051_bib11","first-page":"985","article-title":"c-fos expression is required during all phases of the cell cycle during exponential cell proliferation","volume":"14","author":"Pai","year":"1994","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jaci.2015.10.051_bib12","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.3748\/wjg.14.6339","article-title":"c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear cyclin D1","volume":"14","author":"G\u00fcller","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaci.2015.10.051_bib13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jcp.21951","article-title":"Thrombin stimulates RPE cell proliferation by promoting c-Fos-mediated cyclin D1 expression","volume":"222","author":"Parrales","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jaci.2015.10.051_bib14","first-page":"19","article-title":"Encounters with Fos and Jun on the road to AP-1","volume":"1","author":"Abate","year":"1990","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jaci.2015.10.051_bib15","first-page":"1669","article-title":"Acceleration of the G1\/S phase transition by expression of cyclins D1 and E with an inducible system","volume":"14","author":"Resnitzky","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jaci.2015.10.051_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/1947601912459951","article-title":"Models of crk adaptor proteins in cancer","volume":"3","author":"Bell","year":"2012","journal-title":"Genes Cancer"},{"key":"10.1016\/j.jaci.2015.10.051_bib17","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1038\/onc.2012.590","article-title":"Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth","volume":"32","author":"Yeung","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.jaci.2015.10.051_bib18","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1007\/s13277-013-0851-7","article-title":"Overexpression of CRKL correlates with malignant cell proliferation in breast cancer","volume":"34","author":"Zhao","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jaci.2015.10.051_bib19","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/mc.21935","article-title":"Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer","volume":"52","author":"Wang","year":"2013","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.jaci.2015.10.051_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/85855","article-title":"Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome","volume":"27","author":"Guris","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2015.10.051_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.devcel.2005.12.003","article-title":"Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes","volume":"10","author":"Moon","year":"2006","journal-title":"Dev Cell"},{"key":"10.1016\/j.jaci.2015.10.051_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.devcel.2005.12.002","article-title":"Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of partial DiGeorge syndrome","volume":"10","author":"Guris","year":"2006","journal-title":"Dev Cell"},{"key":"10.1016\/j.jaci.2015.10.051_bib23","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jpeds.2014.01.056","article-title":"Clinical features and follow-up in patients with 22q11.2 deletion syndrome","volume":"164","author":"Cancrini","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2015.10.051_bib24","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/hmg\/9.16.2421","article-title":"The 22q11 deletion syndromes","volume":"9","author":"Scambler","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaci.2015.10.051_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1471-4914(03)00141-2","article-title":"Unraveling the genetic and developmental mysteries of 22q11 deletion syndrome","volume":"9","author":"Yamagishi","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jaci.2015.10.051_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.diff.2012.04.005","article-title":"The neural crest in cardiac congenital anomalies","volume":"84","author":"Keyte","year":"2012","journal-title":"Differentiation"},{"key":"10.1016\/j.jaci.2015.10.051_bib27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF01995856","article-title":"The DiGeorge sequence. II. Immunologic findings in partial and complete forms of the disorder","volume":"149","author":"M\u00fcller","year":"1989","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaci.2015.10.051_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/clin.1997.4463","article-title":"Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes","volume":"86","author":"Sullivan","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaci.2015.10.051_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-3476(98)70478-0","article-title":"Complete DiGeorge syndrome: persistence of profound immunodeficiency","volume":"132","author":"Markert","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2015.10.051_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1074-7613(00)80025-4","article-title":"Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells","volume":"10","author":"Moriggl","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2015.10.051_bib31","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.4049\/jimmunol.166.3.1723","article-title":"4th, Lord JD, Moon JJ, Nelson BH. Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2","volume":"166","author":"Martino","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2015.10.051_bib32","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/emboj\/18.5.1367","article-title":"Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells","volume":"18","author":"Matsumura","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.jaci.2015.10.051_bib33","doi-asserted-by":"crossref","first-page":"8934","DOI":"10.1128\/MCB.23.24.8934-8945.2003","article-title":"STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression","volume":"23","author":"Magn\u00e9","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jaci.2015.10.051_bib34","doi-asserted-by":"crossref","first-page":"20608","DOI":"10.1074\/jbc.271.34.20608","article-title":"Cyclin D1 expression is regulated positively by the p42\/p44MAPK and negatively by the p38\/HOGMAPK pathway","volume":"271","author":"Lavoie","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2015.10.051_bib35","doi-asserted-by":"crossref","first-page":"17115","DOI":"10.1073\/pnas.0805239105","article-title":"Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development","volume":"105","author":"Newbern","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2015.10.051_bib36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0092-8674(88)90076-1","article-title":"The c-Fos protein interacts with c-Jun\/AP-1 to stimulate transcription of AP-1 responsive genes","volume":"54","author":"Chiu","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2015.10.051_bib37","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1002\/j.1460-2075.1994.tb06608.x","article-title":"Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes","volume":"13","author":"Hu","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.jaci.2015.10.051_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ijc.25997","article-title":"Knockdown of c-Fos suppresses the growth of human colon carcinoma cells in athymic mice","volume":"130","author":"Pandey","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaci.2015.10.051_bib39","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s13277-014-2706-2","article-title":"CRKL protein overexpression enhances cell proliferation and invasion in pancreatic cancer","volume":"36","author":"Fu","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jaci.2015.10.051_bib40","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jaci.2015.01.011","article-title":"Molecular mechanisms of functional natural killer deficiency in patients with partial DiGeorge syndrome","volume":"135","author":"Zheng","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2015.10.051_bib41","first-page":"E35","article-title":"CRKL promotes lung cancer cell invasion through ERK-MMP9 pathway","volume":"54","author":"Lin","year":"2015","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.jaci.2015.10.051_bib42","doi-asserted-by":"crossref","first-page":"30154","DOI":"10.1074\/jbc.274.42.30154","article-title":"CrkL mediates Ras-dependent activation of the Raf\/ERK pathway through the guanine nucleotide exchange factor C3G in hematopoietic cells stimulated with erythropoietin or interleukin-3","volume":"274","author":"Nosaka","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2015.10.051_bib43","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.4049\/jimmunol.161.9.4627","article-title":"The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule Shc","volume":"161","author":"Lord","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2015.10.051_bib44","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0021-9258(17)42066-7","article-title":"The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation","volume":"269","author":"Ravichandran","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2015.10.051_bib45","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1128\/MCB.20.19.7109-7120.2000","article-title":"Cloning of p97\/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation","volume":"20","author":"Gu","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jaci.2015.10.051_bib46","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1128\/MCB.20.19.7109-7120.2000","article-title":"New role for Shc in activation of the phosphatidylinositol 3-kinase\/Akt pathway","volume":"20","author":"Gu","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jaci.2015.10.051_bib47","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.4049\/jimmunol.162.4.2081","article-title":"IL-2, but not IL-4 and other cytokines, induce phosphorylation of a 98-kDa protein associated with SHP-2, phosphatidylinositol 3'-kinase, and Grb2","volume":"162","author":"Gadina","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2015.10.051_bib48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/1074-7613(95)90140-X","article-title":"Identification and purification of human Stat proteins activated in response to interleukin-2","volume":"2","author":"Hou","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2015.10.051_bib49","doi-asserted-by":"crossref","first-page":"10772","DOI":"10.1073\/pnas.92.23.10772","article-title":"Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes","volume":"92","author":"Gilmour","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2015.10.051_bib50","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.4049\/jimmunol.162.7.3897","article-title":"JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response","volume":"162","author":"Wang","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2015.10.051_bib51","doi-asserted-by":"crossref","first-page":"36174","DOI":"10.1074\/jbc.M100731200","article-title":"T cell activation induces direct binding of the Crk adapter protein to the regulatory subunit of phosphatidylinositol 3-kinase (p85) via a complex mechanism involving the Cbl protein","volume":"276","author":"Gelkop","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2015.10.051_bib52","doi-asserted-by":"crossref","first-page":"21519","DOI":"10.1074\/jbc.274.31.21519","article-title":"T cell activation stimulates the association of enzymatically active tyrosine-phosphorylated ZAP-70 with the Crk adapter proteins","volume":"274","author":"Gelkop","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2015.10.051_bib53","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1083\/jcb.200801121","article-title":"The WAVE2 complex regulates T cell receptor signaling to integrins via Abl- and CrkL-C3G-mediated activation of Rap1","volume":"182","author":"Nolz","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jaci.2015.10.051_bib54","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1084\/jem.177.4.1221","article-title":"Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation","volume":"177","author":"Rapoport","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2015.10.051_bib55","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.4049\/jimmunol.146.11.3763","article-title":"Defective thymic T cell activation by concanavalin A\u00a0and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis","volume":"146","author":"Zipris","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2015.10.051_bib56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1084\/jem.178.1.87","article-title":"Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice","volume":"178","author":"Rapoport","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2015.10.051_bib57","doi-asserted-by":"crossref","first-page":"10828","DOI":"10.1021\/bi700537e","article-title":"Proapoptotic function of the nuclear Crk II adaptor protein","volume":"46","author":"Kar","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaci.2015.10.051_bib58","doi-asserted-by":"crossref","first-page":"8670","DOI":"10.1073\/pnas.94.16.8670","article-title":"Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region","volume":"94","author":"Colucci","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2015.10.051_bib59","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1158\/2159-8290.CD-11-0046","article-title":"Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers","volume":"1","author":"Cheung","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jaci.2015.10.051_bib60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2249.2000.01247.x","article-title":"T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome","volume":"121","author":"Pierdominici","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2015.10.051_bib61","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.clim.2010.04.011","article-title":"Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome)","volume":"136","author":"Zemble","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2015.10.051_bibE1","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1038\/ncomms7061","article-title":"Chromatin remodelling and autocrine TNF\u03b1 are required for optimal interleukin-6 expression in activated human neutrophils","volume":"6","author":"Zimmermann","year":"2015","journal-title":"Nat Commun"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916000348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916000348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:57:10Z","timestamp":1758790630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674916000348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0091674916000348"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2015.10.051","relation":{},"ISSN":["0091-6749"],"issn-type":[{"type":"print","value":"0091-6749"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of CRKL expression in patients with partial DiGeorge syndrome is associated with impairment of T-cell functions","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2015.10.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}